Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EFAVIRENZ Cause Neurotoxicity? 198 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 198 reports of Neurotoxicity have been filed in association with EFAVIRENZ (Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate). This represents 2.5% of all adverse event reports for EFAVIRENZ.

198
Reports of Neurotoxicity with EFAVIRENZ
2.5%
of all EFAVIRENZ reports
4
Deaths
20
Hospitalizations

How Dangerous Is Neurotoxicity From EFAVIRENZ?

Of the 198 reports, 4 (2.0%) resulted in death, 20 (10.1%) required hospitalization, and 2 (1.0%) were considered life-threatening.

Is Neurotoxicity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EFAVIRENZ. However, 198 reports have been filed with the FAERS database.

What Other Side Effects Does EFAVIRENZ Cause?

Virologic failure (916) Foetal exposure during pregnancy (701) Drug resistance (654) Drug interaction (645) Viral mutation identified (641) Depression (602) Pathogen resistance (567) Maternal exposure during pregnancy (478) Treatment failure (390) Immune reconstitution inflammatory syndrome (301)

What Other Drugs Cause Neurotoxicity?

AXICABTAGENE CILOLEUCEL (1,327) OXALIPLATIN (1,272) METHOTREXATE (1,083) CYCLOPHOSPHAMIDE (763) FLUOROURACIL (735) PACLITAXEL (734) TACROLIMUS (623) BEVACIZUMAB (588) VINCRISTINE (555) CAPECITABINE (553)

Which EFAVIRENZ Alternatives Have Lower Neurotoxicity Risk?

EFAVIRENZ vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL EFAVIRENZ vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL EFAVIRENZ vs EFFEXOR EFAVIRENZ vs EFFIENT EFAVIRENZ vs EFGARTIGIMOD ALFA

Related Pages

EFAVIRENZ Full Profile All Neurotoxicity Reports All Drugs Causing Neurotoxicity EFAVIRENZ Demographics